Trials / Terminated
TerminatedNCT00208351
A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement
Clinical and Radiographic Evaluation to Compare a Polished and Non-polished Collared Stem and a Polished and Non Polished Collarless Stem in Primary Total Hip Replacement
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- DePuy International · Industry
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the 4 designs of the DePuy Ultima LX hip stem and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.
Conditions
- Osteoarthritis
- Post-traumatic Arthritis
- Collagen Disorder
- Avascular Necrosis
- Traumatic Femoral Fractures
- Nonunion of Femoral Fractures
- Congenital Hip Dysplasia
- Slipped Capital Femoral Epiphysis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultima LX Collared Stem - Non-Polished/Blasted Finished | A collared non-polished/blasted finished cementless femoral component for use in total hip replacement. |
| DEVICE | Ultima LX Collared Stem - Polished Finished | A collared polished finished cementless femoral component for use in total hip replacement. |
| DEVICE | Ultima LX Collarless Stem - Non-Polished/Blasted Finished | A collarless non-polished/blasted finished cementless femoral component for use in total hip replacement. |
| DEVICE | Ultima LX Collarless Stem - Polished finished | A collarless polished finished cementless femoral component for use in total hip replacement. |
Timeline
- Start date
- 1997-05-01
- Primary completion
- 2004-11-01
- Completion
- 2015-03-01
- First posted
- 2005-09-21
- Last updated
- 2016-05-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00208351. Inclusion in this directory is not an endorsement.